CaPre (NKPL66)

NKPL66 · Grace Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CaPre (NKPL66), covering 2014-01-08 to 2014-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia [Phase 2]